We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Key Republican Senators Question Drug Industry's Ability to Monitor DTC Ads
Key Republican Senators Question Drug Industry's Ability to Monitor DTC Ads
August 3, 2005
Two powerful Republican senators have expressed skepticism about the drug industry’s ability to self-regulate its direct-to-consumer (DTC) advertising practices under PhRMA’s new code of conduct.